Exploring the Advantages & Disadvantages of Combination Therapies in Improving Clinical Trial Outcomes & Tumour Targeting
- Evaluating how combination therapies can enhance tumour-specific immune responses
- Overcoming challenges with increased toxicity, complex dosing schedules, and variable patient responses to maximise effectiveness of combined regimens
- Discussing strategies to optimise trial design, biomarker selection, and patient stratification to maximise the benefits of combination therapies